Development of bevacizumab encapsulated PLGA nanoparticles for lung carcinoma therapy (2023)
Source: Program. Conference titles: Brazil MRS Meeting. Unidade: IFSC
Subjects: NANOCIÊNCIA, NANOTECNOLOGIA, QUIMIOTERÁPICOS, NEOPLASIAS PULMONARES
ABNT
PEREIRA, Maria Vitória Silva et al. Development of bevacizumab encapsulated PLGA nanoparticles for lung carcinoma therapy. 2023, Anais.. Rio de Janeiro: Sociedade Brasileira de Pesquisa em Materiais - SBPMat, 2023. Disponível em: https://repositorio.usp.br/directbitstream/6e39cd6a-2baa-4c49-9620-767e888674fa/3160206.pdf. Acesso em: 15 set. 2024.APA
Pereira, M. V. S., Rodero, C. F., Suzuki, I. L., & Zucolotto, V. (2023). Development of bevacizumab encapsulated PLGA nanoparticles for lung carcinoma therapy. In Program. Rio de Janeiro: Sociedade Brasileira de Pesquisa em Materiais - SBPMat. Recuperado de https://repositorio.usp.br/directbitstream/6e39cd6a-2baa-4c49-9620-767e888674fa/3160206.pdfNLM
Pereira MVS, Rodero CF, Suzuki IL, Zucolotto V. Development of bevacizumab encapsulated PLGA nanoparticles for lung carcinoma therapy [Internet]. Program. 2023 ;[citado 2024 set. 15 ] Available from: https://repositorio.usp.br/directbitstream/6e39cd6a-2baa-4c49-9620-767e888674fa/3160206.pdfVancouver
Pereira MVS, Rodero CF, Suzuki IL, Zucolotto V. Development of bevacizumab encapsulated PLGA nanoparticles for lung carcinoma therapy [Internet]. Program. 2023 ;[citado 2024 set. 15 ] Available from: https://repositorio.usp.br/directbitstream/6e39cd6a-2baa-4c49-9620-767e888674fa/3160206.pdf